AVITHRAPID
@avithrapid.bsky.social
The EU-funded project AVITHRAPID aims to develop broad spectrum antiviral therapeutics for infectious diseases with epidemic – and subsequently pandemic – potential.
Science is closer than you think. 🔬🌍
On 25 September, the European Researchers’ Night will connect researchers and citizens across Europe.
At AVITHRAPID, we celebrate those working together to develop new solutions against emerging viral threats.
avithrapid.eu
On 25 September, the European Researchers’ Night will connect researchers and citizens across Europe.
At AVITHRAPID, we celebrate those working together to develop new solutions against emerging viral threats.
avithrapid.eu
August 25, 2026 at 6:48 AM
Science is closer than you think. 🔬🌍
On 25 September, the European Researchers’ Night will connect researchers and citizens across Europe.
At AVITHRAPID, we celebrate those working together to develop new solutions against emerging viral threats.
avithrapid.eu
On 25 September, the European Researchers’ Night will connect researchers and citizens across Europe.
At AVITHRAPID, we celebrate those working together to develop new solutions against emerging viral threats.
avithrapid.eu
🔬 Discover the science behind #AVITHRAPID!
Prof. Vincenzo Summa from the University of Naples introduces Work Package One, dedicated to identifying new chemical entities with broad-spectrum antiviral potential.
Prof. Vincenzo Summa from the University of Naples introduces Work Package One, dedicated to identifying new chemical entities with broad-spectrum antiviral potential.
August 7, 2026 at 7:25 AM
🔬 Discover the science behind #AVITHRAPID!
Prof. Vincenzo Summa from the University of Naples introduces Work Package One, dedicated to identifying new chemical entities with broad-spectrum antiviral potential.
Prof. Vincenzo Summa from the University of Naples introduces Work Package One, dedicated to identifying new chemical entities with broad-spectrum antiviral potential.
Prof. Francesca Ceccherini-Silberstein from the University of Rome Tor Vergata shares how her team is contributing to the project through cutting-edge virological research.
August 5, 2026 at 6:47 PM
Prof. Francesca Ceccherini-Silberstein from the University of Rome Tor Vergata shares how her team is contributing to the project through cutting-edge virological research.
🎥 Elisabeth Reus from the Swiss Tropical and Public Health Institute explains how AVITHRAPID bridges preclinical research and clinical application, helping advance innovative antiviral therapies and improve preparedness for future infectious disease threats.
#AVITHRAPID #SwissTPH #horizoneurope
#AVITHRAPID #SwissTPH #horizoneurope
August 3, 2026 at 6:24 AM
🎥 Elisabeth Reus from the Swiss Tropical and Public Health Institute explains how AVITHRAPID bridges preclinical research and clinical application, helping advance innovative antiviral therapies and improve preparedness for future infectious disease threats.
#AVITHRAPID #SwissTPH #horizoneurope
#AVITHRAPID #SwissTPH #horizoneurope
Prof. Enzo Tramontano from the University of Cagliari shares exciting progress from the project’s research activities.
#AVITHRAPID #Virology #Research #Antivirals #Science #HorizonEurope
#AVITHRAPID #Virology #Research #Antivirals #Science #HorizonEurope
July 16, 2026 at 8:01 AM
Prof. Enzo Tramontano from the University of Cagliari shares exciting progress from the project’s research activities.
#AVITHRAPID #Virology #Research #Antivirals #Science #HorizonEurope
#AVITHRAPID #Virology #Research #Antivirals #Science #HorizonEurope
Today, we asked AVITHRAPID Coordinator Bjoern W. to share his thoughts on the project's progress following the Work Package presentations.
A valuable reflection on our achievements so far and the importance of collaboration in strengthening pandemic preparedness through research and innovation.
A valuable reflection on our achievements so far and the importance of collaboration in strengthening pandemic preparedness through research and innovation.
July 9, 2026 at 2:22 PM
Today, we asked AVITHRAPID Coordinator Bjoern W. to share his thoughts on the project's progress following the Work Package presentations.
A valuable reflection on our achievements so far and the importance of collaboration in strengthening pandemic preparedness through research and innovation.
A valuable reflection on our achievements so far and the importance of collaboration in strengthening pandemic preparedness through research and innovation.
Thanks to Prof.Enzo Tramontano and the University of Cagliari for the warm hospitality. Stay tuned for Day 2! #AVITHRAPID #EUResearch
July 8, 2026 at 8:29 PM
Thanks to Prof.Enzo Tramontano and the University of Cagliari for the warm hospitality. Stay tuned for Day 2! #AVITHRAPID #EUResearch
The @helmholtzhzi.bsky.social is part of the AVITHRAPID consortium, bringing expertise in chemical biology and small-molecule drug discovery to accelerate antiviral innovation.
Together, we're strengthening Europe's preparedness for future viral threats.
#DrugDiscovery #HorizonEurope
Together, we're strengthening Europe's preparedness for future viral threats.
#DrugDiscovery #HorizonEurope
July 3, 2026 at 8:15 AM
The @helmholtzhzi.bsky.social is part of the AVITHRAPID consortium, bringing expertise in chemical biology and small-molecule drug discovery to accelerate antiviral innovation.
Together, we're strengthening Europe's preparedness for future viral threats.
#DrugDiscovery #HorizonEurope
Together, we're strengthening Europe's preparedness for future viral threats.
#DrugDiscovery #HorizonEurope
Face-to-face collaboration remains vital to accelerating drug discovery against emerging viral threats.
#AVITHRAPID #Cagliari2026 #HorizonEurope #OpenScience
#AVITHRAPID #Cagliari2026 #HorizonEurope #OpenScience
June 23, 2026 at 11:00 AM
Face-to-face collaboration remains vital to accelerating drug discovery against emerging viral threats.
#AVITHRAPID #Cagliari2026 #HorizonEurope #OpenScience
#AVITHRAPID #Cagliari2026 #HorizonEurope #OpenScience
Blending technology and virology is how we build a flexible, rapid-response platform to protect global health.
Learn more: https://avithrapid.eu/
#AVITHRAPID #ArtificialIntelligence #DrugDiscovery #OpenScience
Learn more: https://avithrapid.eu/
#AVITHRAPID #ArtificialIntelligence #DrugDiscovery #OpenScience
June 19, 2026 at 12:00 PM
Blending technology and virology is how we build a flexible, rapid-response platform to protect global health.
Learn more: https://avithrapid.eu/
#AVITHRAPID #ArtificialIntelligence #DrugDiscovery #OpenScience
Learn more: https://avithrapid.eu/
#AVITHRAPID #ArtificialIntelligence #DrugDiscovery #OpenScience
By utilizing prior clinical experience responsibly, we aim to accelerate the pathway to drug discovery and build a flexible platform capable of rapid response to emerging threats.
Learn more: https://avithrapid.eu/
#AVITHRAPID #Dengue #Chikungunya #PublicHealth
Learn more: https://avithrapid.eu/
#AVITHRAPID #Dengue #Chikungunya #PublicHealth
June 12, 2026 at 6:52 AM
By utilizing prior clinical experience responsibly, we aim to accelerate the pathway to drug discovery and build a flexible platform capable of rapid response to emerging threats.
Learn more: https://avithrapid.eu/
#AVITHRAPID #Dengue #Chikungunya #PublicHealth
Learn more: https://avithrapid.eu/
#AVITHRAPID #Dengue #Chikungunya #PublicHealth
How AI reduces time in drug discovery: By simulating billions of molecular interactions, #AVITHRAPID identifies the most promising candidates faster than ever. Technology meets biology to accelerate pandemic response. 🤖🧪 #AI #Science #HealthTech
May 28, 2026 at 10:01 AM
How AI reduces time in drug discovery: By simulating billions of molecular interactions, #AVITHRAPID identifies the most promising candidates faster than ever. Technology meets biology to accelerate pandemic response. 🤖🧪 #AI #Science #HealthTech
Innovation needs protection - but also collaboration.
At AVITHRAPID, progress happens where knowledge is shared, connected, and applied to real-world antiviral challenges.
#AVITHRAPID #Innovation #Science
At AVITHRAPID, progress happens where knowledge is shared, connected, and applied to real-world antiviral challenges.
#AVITHRAPID #Innovation #Science
May 19, 2026 at 3:00 PM
Innovation needs protection - but also collaboration.
At AVITHRAPID, progress happens where knowledge is shared, connected, and applied to real-world antiviral challenges.
#AVITHRAPID #Innovation #Science
At AVITHRAPID, progress happens where knowledge is shared, connected, and applied to real-world antiviral challenges.
#AVITHRAPID #Innovation #Science
The goal of #AVITHRAPID? Preparedness. By developing a pipeline of drugs against diverse virus families now, we are creating a shield for the future. Proactive research is the key to global safety. 🌍🔬 #Preparedness #Antiviral #PublicHealth
May 15, 2026 at 10:00 AM
The goal of #AVITHRAPID? Preparedness. By developing a pipeline of drugs against diverse virus families now, we are creating a shield for the future. Proactive research is the key to global safety. 🌍🔬 #Preparedness #Antiviral #PublicHealth
Plant Health = Human Health. 🌿🔬
Today’s #InternationalDayOfPlantHealth reminds us that human safety is tied to our ecosystems. Environmental shifts can drive zoonotic risks.
Today’s #InternationalDayOfPlantHealth reminds us that human safety is tied to our ecosystems. Environmental shifts can drive zoonotic risks.
May 12, 2026 at 1:00 PM
Plant Health = Human Health. 🌿🔬
Today’s #InternationalDayOfPlantHealth reminds us that human safety is tied to our ecosystems. Environmental shifts can drive zoonotic risks.
Today’s #InternationalDayOfPlantHealth reminds us that human safety is tied to our ecosystems. Environmental shifts can drive zoonotic risks.
Hantavirus: Readiness is no longer an option - it is a necessity
The MV Hondius outbreak in May 2026 confirms an alarming reality: viral pressure is constant and unpredictable.
The MV Hondius outbreak in May 2026 confirms an alarming reality: viral pressure is constant and unpredictable.
May 7, 2026 at 2:15 PM
Hantavirus: Readiness is no longer an option - it is a necessity
The MV Hondius outbreak in May 2026 confirms an alarming reality: viral pressure is constant and unpredictable.
The MV Hondius outbreak in May 2026 confirms an alarming reality: viral pressure is constant and unpredictable.
Why discovery is only the first step: Without rigorous clinical validation, a molecule remains just an idea. #AVITHRAPID focuses on the bridge between the lab and the clinic to ensure safe, effective antiviral protection. 🩺✨ #MedicalResearch #PublicHealth
May 6, 2026 at 1:52 PM
Why discovery is only the first step: Without rigorous clinical validation, a molecule remains just an idea. #AVITHRAPID focuses on the bridge between the lab and the clinic to ensure safe, effective antiviral protection. 🩺✨ #MedicalResearch #PublicHealth
Building capacity today for the crises of tomorrow. 🏗️
AVITHRAPID is strengthening Europe’s ability to deploy antiviral solutions responsibly. Sustainable preparedness is an investment, not a reaction.
How should we measure success: outcomes achieved, or capacity built? ⚖️
#AVITHRAPID
AVITHRAPID is strengthening Europe’s ability to deploy antiviral solutions responsibly. Sustainable preparedness is an investment, not a reaction.
How should we measure success: outcomes achieved, or capacity built? ⚖️
#AVITHRAPID
April 9, 2026 at 8:00 AM
Building capacity today for the crises of tomorrow. 🏗️
AVITHRAPID is strengthening Europe’s ability to deploy antiviral solutions responsibly. Sustainable preparedness is an investment, not a reaction.
How should we measure success: outcomes achieved, or capacity built? ⚖️
#AVITHRAPID
AVITHRAPID is strengthening Europe’s ability to deploy antiviral solutions responsibly. Sustainable preparedness is an investment, not a reaction.
How should we measure success: outcomes achieved, or capacity built? ⚖️
#AVITHRAPID
AVITHRAPID Highlights
Last week in Naples, Prof. Vincenzo Summa (Federico II) presented our latest research at the "Italo-French Chair" Final Workshop!
Key focuses:
🔹 PLpro Target progress
🔹 Dengue Clinical Trial updates
Last week in Naples, Prof. Vincenzo Summa (Federico II) presented our latest research at the "Italo-French Chair" Final Workshop!
Key focuses:
🔹 PLpro Target progress
🔹 Dengue Clinical Trial updates
April 3, 2026 at 1:25 PM
AVITHRAPID Highlights
Last week in Naples, Prof. Vincenzo Summa (Federico II) presented our latest research at the "Italo-French Chair" Final Workshop!
Key focuses:
🔹 PLpro Target progress
🔹 Dengue Clinical Trial updates
Last week in Naples, Prof. Vincenzo Summa (Federico II) presented our latest research at the "Italo-French Chair" Final Workshop!
Key focuses:
🔹 PLpro Target progress
🔹 Dengue Clinical Trial updates
From discovery to clinical readiness-by design. 🧬
AVITHRAPID connects preclinical discovery, validation, and data management to bridge the ""valley of death"" in antiviral R&D. Integration is a necessity.
Where do you see the biggest translational gaps in research? 🕳️🏃♂️
#ScienceSky
AVITHRAPID connects preclinical discovery, validation, and data management to bridge the ""valley of death"" in antiviral R&D. Integration is a necessity.
Where do you see the biggest translational gaps in research? 🕳️🏃♂️
#ScienceSky
April 1, 2026 at 8:00 AM
From discovery to clinical readiness-by design. 🧬
AVITHRAPID connects preclinical discovery, validation, and data management to bridge the ""valley of death"" in antiviral R&D. Integration is a necessity.
Where do you see the biggest translational gaps in research? 🕳️🏃♂️
#ScienceSky
AVITHRAPID connects preclinical discovery, validation, and data management to bridge the ""valley of death"" in antiviral R&D. Integration is a necessity.
Where do you see the biggest translational gaps in research? 🕳️🏃♂️
#ScienceSky
AVITHRAPID uses an ethical-by-design approach to ensure we are operationally ready for rapid action. Preparedness is built before recruitment begins.
What is the biggest bottleneck in rapid study activation? ⏳
#ClinicalResearch #AVITHRAPID
What is the biggest bottleneck in rapid study activation? ⏳
#ClinicalResearch #AVITHRAPID
March 25, 2026 at 10:00 AM
AVITHRAPID uses an ethical-by-design approach to ensure we are operationally ready for rapid action. Preparedness is built before recruitment begins.
What is the biggest bottleneck in rapid study activation? ⏳
#ClinicalResearch #AVITHRAPID
What is the biggest bottleneck in rapid study activation? ⏳
#ClinicalResearch #AVITHRAPID
FAIR data is a responsibility, not an afterthought. 📊
AVITHRAPID ensures research is Findable, Accessible, Interoperable, and Reusable. Transparent practices build trust and long-term value. FAIR = Quality. 🧬
What’s your best tip for making data truly FAIR?
#OpenScience #AVITHRAPID
AVITHRAPID ensures research is Findable, Accessible, Interoperable, and Reusable. Transparent practices build trust and long-term value. FAIR = Quality. 🧬
What’s your best tip for making data truly FAIR?
#OpenScience #AVITHRAPID
March 18, 2026 at 12:00 PM
FAIR data is a responsibility, not an afterthought. 📊
AVITHRAPID ensures research is Findable, Accessible, Interoperable, and Reusable. Transparent practices build trust and long-term value. FAIR = Quality. 🧬
What’s your best tip for making data truly FAIR?
#OpenScience #AVITHRAPID
AVITHRAPID ensures research is Findable, Accessible, Interoperable, and Reusable. Transparent practices build trust and long-term value. FAIR = Quality. 🧬
What’s your best tip for making data truly FAIR?
#OpenScience #AVITHRAPID
Formulation matters as much as the molecule. 💊
AVITHRAPID focuses on versatile, scalable delivery strategies to turn scientific potential into practical impact.
How early should delivery enter the R&D process? 🧬
#ScienceSky #R&D
AVITHRAPID focuses on versatile, scalable delivery strategies to turn scientific potential into practical impact.
How early should delivery enter the R&D process? 🧬
#ScienceSky #R&D
March 13, 2026 at 11:00 AM
Formulation matters as much as the molecule. 💊
AVITHRAPID focuses on versatile, scalable delivery strategies to turn scientific potential into practical impact.
How early should delivery enter the R&D process? 🧬
#ScienceSky #R&D
AVITHRAPID focuses on versatile, scalable delivery strategies to turn scientific potential into practical impact.
How early should delivery enter the R&D process? 🧬
#ScienceSky #R&D
Reflecting on the anniversary of the COVID-19 pandemic declaration.
The #AVITHRAPID project is working to build "ready-to-use" antiviral platforms. Our goal? To identify and accelerate treatments for emerging viruses so we can respond to future threats in weeks, not years.
The #AVITHRAPID project is working to build "ready-to-use" antiviral platforms. Our goal? To identify and accelerate treatments for emerging viruses so we can respond to future threats in weeks, not years.
March 11, 2026 at 1:01 PM
Reflecting on the anniversary of the COVID-19 pandemic declaration.
The #AVITHRAPID project is working to build "ready-to-use" antiviral platforms. Our goal? To identify and accelerate treatments for emerging viruses so we can respond to future threats in weeks, not years.
The #AVITHRAPID project is working to build "ready-to-use" antiviral platforms. Our goal? To identify and accelerate treatments for emerging viruses so we can respond to future threats in weeks, not years.